A diagnosis of pancreatic cancer carries a very dismal prognosis, with the 5-year survival rate being the lowest of all types of cancer. Surgical resection offers the only hope for cure in these patients. Pancreatic resectional surgery is technically demanding, and while mortality has decreased in centers of excellence, the morbidity remains significant. Numerous controversies exist regarding various aspects of complex pancreatic resections. This review attempts to address these controversies with an evidence-based perspective. We performed a literature search in MEDLINE (www.pubmed.org) with relevant key words and the corresponding MeSH terms. The search was limited to English language publications on human subjects. A manual cross-referen...
This book contains the art and science in current standards of surgical treatment of pancreatic duct...
Background/Aims: Surgical resection is a radical treatment option for pancreatic carcinoma (PC); how...
Background: In patients with pancreatic cancer 15-20% are resectable at the time of diagnosis. Still...
Abstract Pancreatic cancer surgery continues to be associated with a high operative morbidity rate, ...
BACKGROUND: The extent of pancreatic resection and lymphadenectomy, both for Kausch-Whipple pancreat...
Despite significant improvement in the results of pancreatoduodenecomy over recent years, the Whippl...
The surgical treatment of pancreatic carcinoma, and particularly the decision to resect locally adva...
Pancreatic cancer is the third leading neoplasm of the gastrointestinal system and has a dismal prog...
Pancreatic cancer is a common cause of cancer death in the developed world. Currently, resection is ...
Pancreatic cancer is the third leading neoplasm of the gastrointestinal system and has a dismal prog...
Background: Pancreatic surgery is associated with considerable morbidity and, consequently, offers a...
Pancreatic cancer is the second most common digestive cancer in the United States, with roughly 44,0...
BACKGROUND: There is a growing body of literature pertaining to minimally invasive pancreatic resect...
In this thesis we have presented the results of 5 years of basic and clinical research on pancreatic...
Context Patients with resectable pancreatic cancer comprise a small subgroup of the overall populati...
This book contains the art and science in current standards of surgical treatment of pancreatic duct...
Background/Aims: Surgical resection is a radical treatment option for pancreatic carcinoma (PC); how...
Background: In patients with pancreatic cancer 15-20% are resectable at the time of diagnosis. Still...
Abstract Pancreatic cancer surgery continues to be associated with a high operative morbidity rate, ...
BACKGROUND: The extent of pancreatic resection and lymphadenectomy, both for Kausch-Whipple pancreat...
Despite significant improvement in the results of pancreatoduodenecomy over recent years, the Whippl...
The surgical treatment of pancreatic carcinoma, and particularly the decision to resect locally adva...
Pancreatic cancer is the third leading neoplasm of the gastrointestinal system and has a dismal prog...
Pancreatic cancer is a common cause of cancer death in the developed world. Currently, resection is ...
Pancreatic cancer is the third leading neoplasm of the gastrointestinal system and has a dismal prog...
Background: Pancreatic surgery is associated with considerable morbidity and, consequently, offers a...
Pancreatic cancer is the second most common digestive cancer in the United States, with roughly 44,0...
BACKGROUND: There is a growing body of literature pertaining to minimally invasive pancreatic resect...
In this thesis we have presented the results of 5 years of basic and clinical research on pancreatic...
Context Patients with resectable pancreatic cancer comprise a small subgroup of the overall populati...
This book contains the art and science in current standards of surgical treatment of pancreatic duct...
Background/Aims: Surgical resection is a radical treatment option for pancreatic carcinoma (PC); how...
Background: In patients with pancreatic cancer 15-20% are resectable at the time of diagnosis. Still...